Synektik

Synektik FCF Margin

The Free Cash Flow Margin of Synektik (SNT.WA) as of Oct 31, 2026 is 8.75 %. In the previous year, Free Cash Flow Margin was 7.17 % — a change of 22.01% (higher).

FCF Margin

8.75 %

YoY

22.01%

Last updated:

Free Cash Flow Margin of Synektik is 2025 8.75 % . Free Cash Flow Margin of Synektik was 2024 7.17 % . It decreases by 22.01% higher compared to the previous year.

The Synektik FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
2.71 PLN
Jan 1, 2019
5.96 PLN
Jan 1, 2020
7.03 PLN
Jan 1, 2021
14.21 PLN
Jan 1, 2022
-9.83 PLN
Jan 1, 2023
19.29 PLN
Jan 1, 2024
7.17 PLN
Jan 1, 2025
8.75 PLN
The Synektik FCF Margin history
YEARFCF MarginYoY
8.75 %+22.01%
7.17 %-62.84%
19.29 %-296.20%
-9.83 %-169.18%
14.21 %+102.19%
7.03 %+17.94%
5.96 %+120.22%
2.71 %-78.39%
12.52 %-141.15%
-30.43 %+423.72%
-5.81 %+44.88%
-4.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Free Cash Flow Margin of Synektik is 8.75 % in 2025.

Free Cash Flow Margin of Synektik changed from 7.17 % to 8.75 %, representing a 22.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Synektik since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Synektik with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Synektik

All Key Metrics — Synektik